• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瓣膜功能不全的数量是血液透析患者心血管和全因死亡率的强有力预测指标。

The number of valvular insufficiency is a strong predictor of cardiovascular and all-cause mortality in hemodialysis patients.

机构信息

Department of Nephrology, Wuhan Fourth Hospital, Puai Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.

Department of Ophthalmology, Tongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Huazhong University of Science and Technology, Wuhan, Hubei, China.

出版信息

Int Urol Nephrol. 2023 Nov;55(11):2915-2924. doi: 10.1007/s11255-023-03576-3. Epub 2023 Apr 3.

DOI:10.1007/s11255-023-03576-3
PMID:37010736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10560163/
Abstract

OBJECTIVES

To investigate the relationship between the number of valvular insufficiency (VI) and emergency hospitalization or mortality in maintenance hemodialysis (HD) patients.

METHODS

The maintenance HD patients with cardiac ultrasonography were included. According to the number of VI ≥ 2 or not, the patients were divided into two groups. The difference of emergency hospitalized for acute heart failure, arrhythmia, acute coronary syndrome (ACS) or stroke, cardiovascular mortality, and all-cause mortality between the two groups were compared.

RESULTS

Among 217 maintenance HD patients, 81.57% had VI. 121 (55.76%) patients had two or more VI, and 96 (44.24%) with one VI or not. The study subjects were followed up for a median of 47 (3-107) months. At the end of the follow up, 95 patients died (43.78%), of whom 47 (21.66%) patients died because of cardiovascular disease. Age (HR 1.033, 95% CI 1.007-1.061, P = 0.013), number of VI ≥ 2 (HR 2.035, 95% CI 1.083-3.821, P = 0.027) and albumin (HR 0.935, 95% CI 0.881-0.992, P = 0.027) were independent risk factors for cardiovascular mortality. The three parameters were also independent risk factors for all-cause mortality. The patients with number of VI ≥ 2 were more likely to be emergency hospitalized for acute heart failure (56 [46.28%] vs 11 [11.46%], P = 0.001). On the contrary, the number of VI was not associated with emergency hospitalized for arrhythmia, ACS or stroke. Survival analysis results showed that probability of survival was statistically different in the two groups (P < 0.05), no matter based on cardiovascular mortality or all-cause mortality. Based on age, number of VI ≥ 2 and albumin, nomogram models for 5-year cardiovascular and all-cause mortality were built.

CONCLUSIONS

In maintenance HD patients, the prevalence of VI is prominently high. The number of VI ≥ 2 is associated with emergency hospitalized for acute heart failure, cardiovascular and all-cause mortality. Combining age, number of VI ≥ 2, and albumin can predict cardiovascular and all-cause mortality.

摘要

目的

探讨维持性血液透析(HD)患者心脏瓣膜反流(VI)数量与急诊住院或死亡的关系。

方法

纳入行心脏超声检查的维持性 HD 患者。根据 VI≥2 或否,将患者分为两组。比较两组间因急性心力衰竭、心律失常、急性冠状动脉综合征(ACS)或卒中急诊住院、心血管死亡率和全因死亡率的差异。

结果

在 217 例维持性 HD 患者中,81.57%存在 VI。121 例(55.76%)患者存在 2 种或以上 VI,96 例(44.24%)存在 1 种或无 VI。中位随访时间为 47(3-107)个月。随访结束时,95 例患者死亡(43.78%),其中 47 例(21.66%)死于心血管疾病。年龄(HR 1.033,95%CI 1.007-1.061,P=0.013)、VI≥2(HR 2.035,95%CI 1.083-3.821,P=0.027)和白蛋白(HR 0.935,95%CI 0.881-0.992,P=0.027)是心血管死亡率的独立危险因素。这 3 个参数也是全因死亡率的独立危险因素。VI≥2 的患者更易因急性心力衰竭急诊住院(56[46.28%] vs 11[11.46%],P=0.001)。相反,VI 数量与心律失常、ACS 或卒中急诊住院无关。生存分析结果显示,两组间生存概率有统计学差异(P<0.05),无论是基于心血管死亡率还是全因死亡率。基于年龄、VI≥2 和白蛋白,构建了 5 年心血管和全因死亡率的列线图模型。

结论

在维持性 HD 患者中,VI 患病率显著较高。VI≥2 与急性心力衰竭急诊住院、心血管和全因死亡率相关。结合年龄、VI≥2 和白蛋白可以预测心血管和全因死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/ea9397078069/11255_2023_3576_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/778c9b56c766/11255_2023_3576_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/47dba471c61b/11255_2023_3576_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/8dcc1b90c4a4/11255_2023_3576_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/59ac0acfc90c/11255_2023_3576_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/263250ef20b6/11255_2023_3576_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/ea9397078069/11255_2023_3576_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/778c9b56c766/11255_2023_3576_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/47dba471c61b/11255_2023_3576_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/8dcc1b90c4a4/11255_2023_3576_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/59ac0acfc90c/11255_2023_3576_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/263250ef20b6/11255_2023_3576_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e71/10560163/ea9397078069/11255_2023_3576_Fig6_HTML.jpg

相似文献

1
The number of valvular insufficiency is a strong predictor of cardiovascular and all-cause mortality in hemodialysis patients.瓣膜功能不全的数量是血液透析患者心血管和全因死亡率的强有力预测指标。
Int Urol Nephrol. 2023 Nov;55(11):2915-2924. doi: 10.1007/s11255-023-03576-3. Epub 2023 Apr 3.
2
Association of cardiac valvular calcifications and C-reactive protein with cardiovascular mortality in incident hemodialysis patients: a Japanese cohort study.在新发生血液透析患者中,心脏瓣膜钙化和 C 反应蛋白与心血管死亡率的关系:一项日本队列研究。
Am J Kidney Dis. 2013 Feb;61(2):254-61. doi: 10.1053/j.ajkd.2012.09.007. Epub 2012 Nov 2.
3
Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients.血液透析患者的心脏瓣膜钙化、生存率及心血管风险
Am J Kidney Dis. 2004 Mar;43(3):479-84. doi: 10.1053/j.ajkd.2003.11.009.
4
Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.强化血液透析、左心室肥厚与心血管疾病。
Am J Kidney Dis. 2016 Nov;68(5S1):S5-S14. doi: 10.1053/j.ajkd.2016.05.025.
5
Valvular calcifications at the start of dialysis predict the onset of cardiovascular events in the course of follow-up.透析开始时的瓣膜钙化可预测随访过程中心血管事件的发生。
Nefrologia. 2015;35(2):157-63. doi: 10.1016/j.nefro.2015.05.017. Epub 2015 Jun 23.
6
The influence of cardiac valvular calcification on all-cause and cardiovascular mortality in maintenance hemodialysis patients.维持性血液透析患者心脏瓣膜钙化对全因和心血管死亡率的影响。
Int Urol Nephrol. 2020 May;52(5):943-951. doi: 10.1007/s11255-020-02448-4. Epub 2020 Apr 1.
7
Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.血液透析和腹膜透析患者的透析方式与心血管死亡率比较
Adv Perit Dial. 2016;32:22-31.
8
Ankle brachial pressure index but not brachial-ankle pulse wave velocity is a strong predictor of systemic atherosclerotic morbidity and mortality in patients on maintenance hemodialysis.踝臂血压指数而非肱踝脉搏波速度是维持性血液透析患者系统性动脉粥样硬化发病率和死亡率的强有力预测指标。
Atherosclerosis. 2011 Dec;219(2):643-7. doi: 10.1016/j.atherosclerosis.2011.09.037. Epub 2011 Oct 1.
9
Cardiovascular problems in dialysis patients: impact on survival.透析患者的心血管问题:对生存的影响。
Adv Perit Dial. 2010;26:47-52.
10
Association of trimethylamine -Oxide with cardiovascular and all-cause mortality in hemodialysis patients.血液透析患者中氧化三甲胺与心血管和全因死亡率的关系。
Ren Fail. 2020 Nov;42(1):1004-1014. doi: 10.1080/0886022X.2020.1822868.

引用本文的文献

1
A novel nomogram for predicting mortality risk in young and middle-aged patients undergoing maintenance hemodialysis: a retrospective study.一种用于预测接受维持性血液透析的中青年患者死亡风险的新型列线图:一项回顾性研究。
Front Med (Lausanne). 2025 Jan 7;11:1508485. doi: 10.3389/fmed.2024.1508485. eCollection 2024.

本文引用的文献

1
Epidemiology of haemodialysis outcomes.血液透析结局的流行病学。
Nat Rev Nephrol. 2022 Jun;18(6):378-395. doi: 10.1038/s41581-022-00542-7. Epub 2022 Feb 22.
2
Systolic pulmonary regurgitation affects the outcome of patients with severe systolic heart failure.收缩期肺瓣反流影响严重收缩性心力衰竭患者的预后。
ESC Heart Fail. 2021 Dec;8(6):5121-5131. doi: 10.1002/ehf2.13581. Epub 2021 Sep 3.
3
Valvular heart disease in patients with chronic kidney disease.慢性肾脏病患者的心脏瓣膜病。
Herz. 2021 Jun;46(3):228-233. doi: 10.1007/s00059-020-05011-0. Epub 2021 Jan 4.
4
Trends in Cardiovascular Mortality Among a Cohort of Children and Young Adults Starting Dialysis in 1995 to 2015.1995 年至 2015 年开始透析的儿童和青年人群中心血管死亡率趋势。
JAMA Netw Open. 2020 Sep 1;3(9):e2016197. doi: 10.1001/jamanetworkopen.2020.16197.
5
Impact of chronic kidney disease on long-term outcome of patients with valvular heart defects.慢性肾脏病对瓣膜性心脏病患者长期预后的影响。
Int Urol Nephrol. 2020 Nov;52(11):2161-2170. doi: 10.1007/s11255-020-02561-4. Epub 2020 Jul 14.
6
The influence of cardiac valvular calcification on all-cause and cardiovascular mortality in maintenance hemodialysis patients.维持性血液透析患者心脏瓣膜钙化对全因和心血管死亡率的影响。
Int Urol Nephrol. 2020 May;52(5):943-951. doi: 10.1007/s11255-020-02448-4. Epub 2020 Apr 1.
7
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
8
Association between Dialysis Modality and Cardiovascular Diseases: A Comparison between Peritoneal Dialysis and Hemodialysis.透析方式与心血管疾病的关联:腹膜透析与血液透析的比较。
Blood Purif. 2020;49(3):302-309. doi: 10.1159/000504040. Epub 2019 Dec 18.
9
Valvular heart disease and calcification in CKD: more common than appreciated.慢性肾脏病中的瓣膜心脏病和钙化:比想象中更常见。
Nephrol Dial Transplant. 2020 Dec 4;35(12):2046-2053. doi: 10.1093/ndt/gfz133.
10
Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis.三尖瓣反流与死亡率升高相关,与肺压和右心衰竭无关:系统评价和荟萃分析。
Eur Heart J. 2019 Feb 1;40(5):476-484. doi: 10.1093/eurheartj/ehy641.